×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateur : Fabrice Lécuru

Au programme de cette soirée

18:00 Introduction
Fabrice Lécuru
 
18:05 Cancer de l'ovaire et oncoGériatrie : réflexions autour de cas cliniques
Florence Rollot, Médecin interniste - Gériatre
 
18:30 La prise en charge nutritionnelle dans le cancer de l'ovaire
Timothée Marchal, Médecin de soins de support, spécialisé en nutrition
 
18:55 Place des soins palliatifs précoces pour les patientes symptomatiques de la carcinose péritonéale
Carole Bouleuc, Médecin de soins palliatifs
 
19:20 Débat/Discussion et réponses aux questions
 

 

Shooting date : 2022-11-15
Last update : 2022-11-16
1 comment
Join the Discussion
  • NADIA A. Merci à tous les quatre

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Tuesday, April 29th 2025 from 01pm to 01:45pm (GMT+2)
    Honolulu : Tuesday, April 29th 2025 from 01am to 01:45am (GMT+2)
    San Francisco : Tuesday, April 29th 2025 from 04am to 04:45am (GMT+2)
    New York : Tuesday, April 29th 2025 from 07am to 07:45am (GMT+2)
    Buenos Aires : Tuesday, April 29th 2025 from 08am to 08:45am (GMT+2)
    Reykjavik : Tuesday, April 29th 2025 from 11am to 11:45am (GMT+2)
    London / Dublin : Tuesday, April 29th 2025 from 12pm to 12:45pm (GMT+2)
    Paris / Berlin : Tuesday, April 29th 2025 from 01pm to 01:45pm (GMT+2)
    Istanbul : Tuesday, April 29th 2025 from 02pm to 02:45pm (GMT+2)
    Moscou / Dubaï : Tuesday, April 29th 2025 from 03pm to 03:45pm (GMT+2)
    Bangkok : Tuesday, April 29th 2025 from 06pm to 06:45pm (GMT+2)
    Shanghai : Tuesday, April 29th 2025 from 07pm to 07:45pm (GMT+2)
    Tokyo : Tuesday, April 29th 2025 from 08pm to 08:45pm (GMT+2)
    Sydney : Tuesday, April 29th 2025 from 10pm to 10:45pm (GMT+2)
    Wellington : Wednesday, April 30th 2025 from 12am to 12:45am (GMT+2)

    Comment prendre en charge un cancer de l'endomètre avancé ?

    Cancer de l’endomètre avancé pMMR NSMP (épisode 4)

    Share
    Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Monday, November 28th 2022 from 06am to 07:30am (GMT+1)
    San Francisco : Monday, November 28th 2022 from 08am to 09:30am (GMT+1)
    New York : Monday, November 28th 2022 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Monday, November 28th 2022 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Monday, November 28th 2022 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Monday, November 28th 2022 from 05pm to 06:30pm (GMT+1)
    Istanbul : Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Monday, November 28th 2022 from 08pm to 09:30pm (GMT+1)
    Bangkok : Monday, November 28th 2022 from 11pm to 12:30am (GMT+1)
    Shanghai : Tuesday, November 29th 2022 from 12am to 01:30am (GMT+1)
    Tokyo : Tuesday, November 29th 2022 from 01am to 02:30am (GMT+1)
    Sydney : Tuesday, November 29th 2022 from 02am to 03:30am (GMT+1)
    Wellington : Tuesday, November 29th 2022 from 04am to 05:30am (GMT+1)

    Prise en charge du cancer de l’ovaire avancé à l’ère de la médecine de précision en 2022

    Share
    Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Thursday, March 14th 2024 from 06am to 07:30am (GMT+1)
    San Francisco : Thursday, March 14th 2024 from 08am to 09:30am (GMT+1)
    New York : Thursday, March 14th 2024 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Thursday, March 14th 2024 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Thursday, March 14th 2024 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Thursday, March 14th 2024 from 05pm to 06:30pm (GMT+1)
    Istanbul : Thursday, March 14th 2024 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Thursday, March 14th 2024 from 08pm to 09:30pm (GMT+1)
    Bangkok : Thursday, March 14th 2024 from 11pm to 12:30am (GMT+1)
    Shanghai : Friday, March 15th 2024 from 12am to 01:30am (GMT+1)
    Tokyo : Friday, March 15th 2024 from 01am to 02:30am (GMT+1)
    Sydney : Friday, March 15th 2024 from 02am to 03:30am (GMT+1)
    Wellington : Friday, March 15th 2024 from 04am to 05:30am (GMT+1)

    Prise en charge du cancer de l’ovaire en L1 en région Nord/Normandie : où en sommes-nous ?

    Cycle d'enseignement sur le cancer de l'ovaire - Troisième session

    Share
    Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Wednesday, February 7th 2024 from 06am to 07:30am (GMT+1)
    San Francisco : Wednesday, February 7th 2024 from 08am to 09:30am (GMT+1)
    New York : Wednesday, February 7th 2024 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Wednesday, February 7th 2024 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Wednesday, February 7th 2024 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Wednesday, February 7th 2024 from 05pm to 06:30pm (GMT+1)
    Istanbul : Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Wednesday, February 7th 2024 from 08pm to 09:30pm (GMT+1)
    Bangkok : Wednesday, February 7th 2024 from 11pm to 12:30am (GMT+1)
    Shanghai : Thursday, February 8th 2024 from 12am to 01:30am (GMT+1)
    Tokyo : Thursday, February 8th 2024 from 01am to 02:30am (GMT+1)
    Sydney : Thursday, February 8th 2024 from 02am to 03:30am (GMT+1)
    Wellington : Thursday, February 8th 2024 from 04am to 05:30am (GMT+1)

    Toxicités hématologiques des inhibiteurs de PARP

    Regards croisés oncologue-hématologue-interniste

    Share
    Scroll Up